// App-Quantinova.ai

2013 : The PAX3-FOXO1 oncogene drives aneuploidy and overrides aneuploidy-associated proliferative defects in alveolar rhabdomyosarcoma

Researchers

Presenter

  • Andrew D. Hollenbach

Principal Investigators

  • Jacob M. Loupe

  • Patrick J. Miller

  • Benjamin P. Bonner

  • Elaine C. Maggi

  • Jyothi Vijayaraghavan

  • Jovanny Zabaleta

  • Christopher M. Taylor

  • Fern Miller

  • Judy S. Crabtree

Medical Centers

  • Louisiana State University Health Sciences Center New Orleans, New Orleans, LA

  • Massachusetts General Hospital, Boston, MA

  • Tulane University Medical School, New Orleans, LA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Rhabdomyosarcoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A